Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- Parvus Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06798454
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
News
No news found